Development of three-dimensional printing polymer-ceramic scaffolds with enhanced compressive properties and tuneable resorption by Zhou, Zuoxin et al.
UN
CO
RR
EC
TE
D
PR
OO
F
Materials Science & Engineering C xxx (2018) xxx-xxx
Contents lists available at ScienceDirect
Materials Science & Engineering C
journal homepage: www.elsevier.com
Development of three-dimensional printing polymer-ceramic scaffolds with enhanced
compressive properties and tuneable resorption
Zuoxin Zhou⁠a, Eoin Cunningham ⁠b, Alex Lennon ⁠b, Helen McCarthy ⁠d, Fraser Buchanan ⁠b, Nicholas Dunne ⁠c⁠, ⁠d⁠, ⁠e⁠, ⁠f⁠, ⁠⁎
a Centre for Additive Manufacturing, Faculty of Engineering, The University of Nottingham, UK
b School of Mechanical and Aerospace Engineering, Queen's University Belfast, UK
c School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland
d Centre for Medical Engineering Research, School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland
e School of Pharmacy, Queen's University Belfast, UK
f Trinity Centre for Bioengineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland
A R T I C L E I N F O
Keywords:
Additive manufacturing
3D printing
Hydroxyapatite
Calcium sulphate
Poly(ε‑caprolactone)
Tissue-engineering bone scaffold
Dynamic resorption
A B S T R A C T
In this study, bone tissue engineered scaffolds fabricated via powder-based 3D printing from hydroxyapatite (HA)
and calcium sulphate (CaSO⁠4) powders were investigated. The combination of using a fast resorbing CaSO⁠4 based
powder and the relatively slower HA powder represents a promising prospect for tuning the bioresorption of 3D
printed (3DP) scaffolds. These properties could then be tailored to coincide with tissue growth rate for different
surgical procedures. The manufactured scaffolds were infiltrated with poly(ε‑caprolactone) (PCL). The PCL infil-
trated the inter-particle spacing within the 3DP structures due to the nature of a loosely-packed powder bed and
also covered the surface of ceramic-based scaffolds. Consequently, the average compressive strength, compres-
sive modulus and toughness increased by 314%, 465% and 867%, respectively. The resorption behaviour of the
3DP scaffolds was characterised in vitro using a high-throughput system that mimicked the physiological envi-
ronment and dynamic flow conditions relevant to the human body. A rapid release of CaSO⁠4 between Day 0 and
28 was commensurate with a reduction in scaffold mass and compressive properties, as well as an increase in
medium absorption. In spite of this, HA particles, connected by PCL fibrils, remained within the microstructure
after 56days resorption under dynamic conditions. Consequently, a high level of structural integrity was main-
tained within the 3DP scaffold. This study presented a porous PCL-HA-CaSO⁠4 3DP structure with the potential to
encourage new tissue growth during the initial stages of implantation and also offering sufficient structural and
mechanical support during the bone healing phase.
1. Introduction
Additive Manufacturing (AM) has been highly recognised as a
promising tool to fabricate patient-specific bone substitutes for the re-
placement and restoration of lost or irreparable bone tissues due to its
unique ability to fully control the complex external shape and internal
porous network for the printed scaffold. A virtual scaffold design can
be directly generated from the computed tomography (CT) or magnetic
resonance imaging (MRI) data for an individual patient. A precise con-
struction of a three-dimensional (3D) structure allows prediction and
monitoring of biomechanical behaviour of the scaffold and ensures that
it provides sufficient support to the surrounding tissues and dynamic re-
sorption to match the rate of newly-formed tissue ingrowth. Such de
velopments are crucial for the future of the interdisciplinary field of
bone tissue engineering.
Powder-based inkjet 3D printing is an AM technology that builds a
pre-defined structure via depositing binder droplets selectively on pow-
der layers. The selection of powder and binder formulation is the key
to a successful 3D printing process as it determines the green strength
and structural integrity of a 3D printed (3DP) structure, as well as the
reliability of the entire printing system. The 3D printing processabil-
ity of calcium phosphate (CaP), which is the inorganic constituent of
natural bone, has been investigated by introducing different binding
approaches. Previous attempts have formulated acidic binders to initi-
ate setting reactions between CaP and acids, or polymeric binders to
glue CaP powder via polymer precipitation [1–5]. However, proprietary
3D printing systems are typically equipped with a thermally activated
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Fig. 1. (top) Experimental set-up for characterisation of in vitro resorption of 3DP scaffolds under dynamic flow conditions. (bottom) Top and side views of the scaffold chamber. Direction
of fluid flow is indicated by the red arrows. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
print-head, which only works reliably when water-based inks are used
[6,7]. The use of acidic or polymeric binders can significantly com-
promise the working life and performance of these thermally activated
print-heads. To eliminate the use of incompatible binders, some stud-
ies have incorporated in-bed binding adhesives into CaP powder bed
designed to achieve high reactivity between the powder mixture and
the standard water-based binder. Typical binding adhesives that have
been used include starch [8], maltodextrin [9], and polyvinyl alco-
hol [10,11]. However, removal of these binding adhesives during the
post-processing stage has resulted in relatively high levels of shrinkage
(18–20%) [1,12]. A previous study proposed using a highly 3D printable
bioceramic material, calcium sulphate (CaSO⁠4), and a binding adhesive
for CaP powder [7]. A setting reaction occurred between CaSO⁠4 and wa-
ter-based binder, which solidified surrounding powders and, thus, of-
fered high green strength for the printed structure.
Both CaP and CaSO⁠4 can be resorbed by the host through chemi-
cal dissolution and osteoclast resorption processes [13]. However, these
two materials have different resorption rates. The resorption of CaSO⁠4
occurs during the early stages of implantation, often within a month
[14,15]. Resorption of CaP occurs at a slower rate than CaSO⁠4 [16]. The
most stable form of CaP, hydroxyapatite (HA), demonstrates a resorp-
tion period of 12–36months [17]. Ideally, the resorption rate required
for the complete repair of a bone defect should coincide with the natural
healing rate [18]. The challenge is that most biomaterials do not solely
exhibit a resorption rate that matches the typical rate of bone formation
[19]. The concept of combining CaSO⁠4 and CaP to balance the resorp-
tion rate has been proposed in many studies [20–22]. It has been re-
ported that the CaP-CaSO⁠4 composite exhibited a resorption rate closely
matching the rate of new bone formation [19]. Here the rapid disso-
lution of CaSO⁠4 during the early stages of implantation created porous
spaces favouring cell activity, while HA remained and acted as a support
for newly formed tissue [23,24]. The incorporation of HA into CaSO⁠4
could also enhance osteoconductivity due to its crystalline structure and
mineral apatite components analogous to natural bone [19,25].
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Fig. 2. (a) Compressive strength, (b) compressive modulus, and (c) compressive toughness (Mean±SD) for HA-CaSO⁠4 and PCL-HA-CaSO⁠4. ***p<0.001, indicating a significant differ-
ence between HA-CaSO⁠4 and PCL-HA-CaSO⁠4.
Fig. 3. Typical compressive deformation for HA-CaSO⁠4 and PCL-HA-CaSO⁠4 3DP scaffolds and difference in scaffold integrity post-failure. Scale bar=10mm.
In this study, bioceramic scaffolds were 3DP from a HA-CaSO⁠4 pow-
der formulation. The printed scaffolds were post-treated using
poly(ε‑caprolactone) (PCL) to infiltrate the inter-particle spacing; PCL
infiltration was demonstrated as a highly efficient method to improve
the overall performance of 3DP bioceramic scaffolds [26]. The com-
pressive properties, microstructural morphologies and in vitro resorption
behaviour, under dynamic flow conditions, of 3DP composite scaffolds
were subsequently investigated.
2. Materials and methods
2.1. Materials
The combination of 25wt% HA (Capital®, Plasma Biotal Ltd., UK)
and 75wt% hemihydrate CaSO⁠4 powder (ZP102, Z Corporation, UK)
was used as the powdered material for 3DP manufacturing. The HA
powder was milled using a planetary mill (Pulverisette 6, Fristch GmbH,
Germany) and then sieved so as to achieve a particle size distribu-
tion similar to the hemihydrate CaSO⁠4 powder, which had D⁠10, D⁠50,
and D⁠90 equal to 45.68μm, 65.35μm, and 94.40μm, as measured by
laser diffraction using a two laser Sympatec HELOS/BF Particle Sizer
(Sympatec Ltd., UK). Detailed powder preparation procedures were
reported in a previous study [7]. Standard water-based binder (ZB
7, Z Corporation, UK) was used as the binder material. PCL powder
(Capa 6506, Perstorp Ltd., UK) was dissolved (12% w/w) in chloroform
(288306, Sigma-Aldrich, UK) using an ADS-HP1 hotplate stirrer (Asynt
Ltd., UK) at 3000RPM until complete dissolution. Tris-HCl buffer solu-
tion (pH=7.4) was used as the physiological medium during the in vitro
resorption test.
2.2. Manufacturing process
A cylindrical porous scaffold (diameter and height=13.2mm, pore
and strut size=1.2mm) was designed and manufactured from the
HA-CaSO⁠4 powder using a ZCorp 310 3D printer (Z Corporation, US).
The design of an interconnected porous structure can vary greatly ac-
cording to its overall porosity and the size, shape and arrangement of
the pores. Ultimately the ideal design should meet geometrical and me
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Fig. 4. SEM images of the surfaces of: (a) HA-CaSO⁠4, arrows indicate inter-particle gaps (200×); (b) PCL-HA-CaSO⁠4 (190×); (c) PCL films filling inter-particle gaps, arrows indicate
PCL coating infiltrating inter-particle gaps (900×); and (d) PCL-HA-CaSO⁠4 with PCL fibrils bridging the fractured surface, arrows indicate PCL bridging between ceramic particles within
fractured surface (350×).
Fig. 5. Mass change (Mean±SD) for PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 following dynamic resorption up to 56days. ***p-value<0.001, indicating a significant difference between
PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 at the same time point.
chanical requirement towards a specific bone tissue engineering appli-
cation in order facilitate effective bone healing. Nevertheless for materi-
als research purposes, a cylindrical shaped specimen of regular porosity
and pore architecture was chosen for this study as it have been previ-
ously used in a successful manner [26]. During the 3DP process, each
binder droplet was selectively deposited on the print bed to build a
cross-sectional layer of the structure. The overall structure was
3D-printed layer by layer consecutively — with a layer thickness of
100μm. After the 3D printing process, the unbound powder was re-
moved using compressed air.
Each 3DP scaffold was fully immersed in the PCL solution for 30s
to obtain PCL infiltration. Thereafter, the 3DP scaffold was removed
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Fig. 6. Water absorption (Mean±SD) for PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 following dynamic resorption up to 56days. ***p-value<0.001, indicating a significant difference between
PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 at the same time point.
Fig. 7. XRD spectra for PCL-HA-CaSO⁠4 after Day 7, 28, and 56 of dynamic in vitro resorption.
and placed in the fume cupboard under dry, low-pressure conditions
for 48h to facilitate solvent evaporation [26]. The untreated and
PCL-treated scaffolds were classified as HA-CaSO⁠4 and PCL-HA-CaSO⁠4,
respectively. Additionally, CaSO⁠4 scaffolds were prepared using the
same 3DP process and PCL treatment (PCL-CaSO⁠4) to enable direct com-
parison during characterisation of the resorption behaviour.
2.3. Compressive properties
Compressive properties of HA-CaSO⁠4 and PCL-HA-CaSO⁠4 were de-
termined using a universal materials test system (EZ50, Lloyds Instru-
ments, UK). A 1kN load cell (XLC 01/2419, Lloyds Instruments, UK)
was used, and the tests were performed at a rate of displacement of
0.5mm/min. The load cell had a load measurement accuracy of ±0.5%
and could read down to 1/200th of its capacity. A total of four scaffolds
were tested for each material composition. Each scaffold was tested
to failure, which was denoted when the load in the post-peak region
had reduced to 80% of the peak load. One thousand force-vs.-displace-
ment data points were then logged for each specimen. The compressive
strength was defined as the maximum load recorded, divided by the ap-
parent cross-section area of the scaffold. The compressive modulus was
determined by measuring the maximum slope within the linear region
of the stress-vs.-strain curve immediately after the toe-in region. Simp-
son's Rule was used to determine the compressive toughness, which was
denoted as the area under the compressive stress-vs.-strain curve to the
point of failure.
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Fig. 8. (a) Compressive strength and (b) compressive modulus (Mean±SD) for PCL-CaSO⁠4 and PCL-HA-CaSO⁠4 following resorption up to 56days. The average percentage change of the
properties at each time point is also shown as a line plot referring to the labelled secondary Y-axis.
Fig. 9. SEM images of (a) the internal structure and (b) the surface of PCL-HA-CaSO⁠4 after Day 56 of dynamic resorption, arrows indicate PCL fibrils.
2.4. Morphology
3DP structures were sectioned longitudinally to facilitate observa-
tion of the internal architecture and morphology using field emission
scanning electron microscope (SEM) (JEOL JSM-6500F, JEOL Ltd.,
Japan) at an operating voltage of 5keV. Each structure was mounted
on an aluminium stub using a cold cure resin (Extec Corp, Enfield,
CT 06083-1258, US), allowed to cure for 24±2h and subsequently
gold-coated using a sputter chamber prior to SEM examination.
2.5. In vitro resorption properties
A high-throughput system was manufactured to facilitate the mea-
surement of the in vitro resorption properties of 12 groups of 4 spec-
imens simultaneously (Fig. 1). Within the system, the physiological
medium was circulated using a 12-channel peristaltic pump in an effort
to create dynamic flow conditions akin to the human body. Each chan-
nel controlled the flow rate of the medium which was connected to each
reservoir and chamber. Each reservoir was sealed and placed in a tem-
perature-controlled water bath to maintain the temperature of Tris-HCl
buffer solution at 37±1°C. Each chamber was designed to con
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Fig. 10. SEM images of the ceramic surfaces on the internal structure of PCL-HA-CaSO⁠4 after Day 0, 28, and 56 of dynamic resorption.
tain a group of scaffolds (n=4). The buffer solution (240mL), circu-
lated throughout the system and refreshed weekly, was equally distrib-
uted to each 3DP scaffold within the group. It was comparable to the
volume of medium (i.e. 60mL) used in previous static in vitro resorption
studies [26].
The in vitro resorption behaviour of HA-CaSO⁠4, PCL-HA-CaSO⁠4, and
PCL-CaSO⁠4 under a dynamic flow condition was evaluated using the
aforementioned system. The rotational speed of the peristaltic pump
was 4.25 RP, which equated to a circulating flow rate of approx. 1mL/
min [27]. This flow rate has previously been used for the culturing of
engineered bone in perfusion bioreactors [27,28]. Note that the actual
flux that 3DP scaffolds experienced may be slightly different from the
setup flow rate as it also depended on other factors, such as pore size.
The resorption properties were measured over a 56-day period. Every
week, a group of scaffolds were removed and characterised.
The wet mass was measured after carefully removing all the excess
water from the structure using sterile filter paper. Each scaffold was
then rinsed with deionised water and dried in an oven at 37±1°C for
48h. The dry mass was then measured. The water absorption (wt%) and
mass change (%) before and after immersion in buffer solution were cal-
culated using Eqs. (1) and (2):
(1)
(2)
where: m⁠0,d =dry mass before immersion in buffer solution (g);
m⁠t,d =dry mass after immersion in buffer solution (g);
m⁠t,w =wet mass after immersion in buffer solution (g).
The compressive properties were also determined for each scaf-
fold following drying as previously described. Although determining
the compressive properties of the 3DP structures under wet conditions
would have been beneficial as this is more representative of the in vivo
environment. Notwithstanding this fact, drying each of the 3DP struc-
tures prior to mechanical testing was chosen as to allow for the non-de-
structive characterisation to be undertaken beforehand.
X-ray diffraction (XRD) analysis was conducted on the different scaf-
fold types using an X-Pert Pro X-ray diffraction system with an X'Celer-
ator X-ray detector (PANalytical Ltd., UK). X'Pert High Score software
was used to identify the phases present in the different scaffold types at
Day 0, 7, 28, and 56.
Each scaffold type was imaged using SEM to observe the effects of
resorption on the microstructure and morphology at Day 0, 7, 28, and
56. X-ray microtomography (μ-CT) was also used to determine the struc-
tural evolution of the 3DP structures in the dry condition as a function
of in vitro resorption using a SkyScan 1174 compact desktop X-ray mi-
cro-tomography (μ-CT) scanner system (SkyScan N.V., Belgium). Specif-
ically, scanning was conducted at medium resolution (600 axial μ-CT
slices with 1024×1024 pixels bitmap image, 16.25μm pixel size). The
micro-focus X-ray source operated at a voltage of 50kV and a current
of 800μA. Aluminium filters (0.75mm) were applied for beam hard-
ening reduction. During the scanning process the specimen stage was
rotated over 360° at a rotation step of 0.51. At each rotation step an
angular shadow projection of the specimen was acquired at an ex-
posure time of 5.5 s. The X- ray shadow projections were then digi-
tised and the acquisition geometry for each scan was extracted from
the dataset of transmission images using a reconstruction programme
(i.e. smoothing=4, ring artefact correction=14 and beam hardening
correction=46%). Grayscales values are proportional to the material
density [29]. One of the challenges of analysing changes in the struc
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Fig. 11. Grayscale histograms for μ-CT results of: (a) PCL-HA-CaSO⁠4 and (b) PCL-CaSO⁠4 following dynamic resorption up to Day 56.
tural properties as a function of resorption time was the continuous shift
in the X-ray absorption peaks on the grayscale histogram due to den-
sity reduction. Therefore, it was difficult to use the same threshold level
for materials demonstrating different resorption behaviour. The upper
and lower threshold levels for reconstructed cross-sectional images were
determined from the grayscale histogram, which was generated using
ImageJ software (National Institutes of Health, USA). The threshold lev-
els were selected in positions that best separated materials from empty
spaces as well as one material phase from another if distinct peaks were
indicated from the histogram. Thereafter, the structural properties of in-
terest (e.g. volume and degree of porosity) were determined using the
SkyScan CT-analyser software (Version1.10.1.0, SkyScanN.V., Belgium).
Further morphological analysis on the reconstructed image dataset was
performed using ImageJ software (National Institutes of Health, USA)
with the BoneJ plugin [30].
2.6. Statistical analysis
Data collected from each experimental test was evaluated for statis-
tical significance using SPSS13.0 software (SPSS, USA). Differences be-
tween treatment groups were assessed using one-way Analysis of Vari-
ance (ANOVA) with post-hoc Bonferroni correction. A p-value <0.05
denoted statistical significance. Data analysis was selected on basis of
normal probability tests.
3. Results and discussion
3.1. Compressive properties
PCL-HA-CaSO⁠4 exhibited significantly higher compressive properties
(p<0.05) than CaP-CaSO⁠4 (Fig. 2). One of the major drawbacks asso-
ciated with scaffold manufacture using powder-based 3D printing tech-
nology is poor mechanical performance due to high inter-particle spaces
within the printed structures [31]. The resulting stress concentrations
yield rapid and catastrophic failure under compressive forces (Fig. 3a).
Compressive loading is the most common mode of loading applied to
bone during normal day-to-day activities. Therefore, it is essential to
improve the compressive properties of tissue engineered bone scaffolds.
The most rational approach to overcome this inherent drawback asso-
ciated with 3DP scaffolds was to fill the inter-particle spaces using a
biocompatible and bioresorbable material following 3D printing. Previ-
ous studies have used biopolymers as infiltration materials to improve
the mechanical properties of 3DP bioceramic scaffolds [26,32–33]. PCL
infiltrating the micropores of the ceramic scaffold increased the in-
terfacial contact area providing a corresponding increase in the
8
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Fig. 12. Reconstruction and binary images of the cross sections of PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 at four time-points of dynamic degradation (Day 0, 7, 28 and 56). The binary images
was obtained using thresholding at two levels (37–255 and 5–37) for PCL-CaSO⁠4 and at one level (24–255) for PCL-HA-CaSO⁠4. Pixels having grayscale in the range denoted in black. Scale
bar=2mm.
Fig. 13. Results determined by μ-CT analysis for material volume loss of PCL-HA-CaSO⁠4 and PCL-CaSO⁠4 scaffolds as a function of dynamic resorption up to Day 56.
compressive properties of the scaffold. In this study, the compressive
strength, compressive modulus and toughness of HA-CaSO⁠4 was signif-
icantly increased (p<0.001) from 0.84±0.06MPa, 13.64±1.76MPa,
and 0.03±0.004 10⁠−6 J/m⁠3 to 2.64±0.18MPa (average 314% ↑),
63.39±4.92MPa (average 465% ↑), and 0.26±0.09 10⁠−6 J/m⁠3 (av-
erage 867% ↑) following PCL infiltration.
The infiltrated PCL-HA-CaSO⁠4 scaffold demonstrated high structural in-
tegrity following compressive loading (Fig. 3b). SEM analysis showed
the PCL covered the surface pores and also infiltrated deep into the in-
ter-particle spaces (Fig. 4). Consequently, the PCL increased the overall
density of 3DP scaffolds, connected the adjacent powder particles, and
bridged cracks in the form of fibrils during compressive loading.
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3.2. In vitro resorption properties
The purpose of an in vitro resorption experiment was to gain a bet-
ter understanding of material resorption trends using methods analo-
gous to in vivo conditions. Resorption under static conditions is the typ-
ical methodology used to evaluate the resorption properties because it
is easier to implement. However, implants are not exposed to static con-
ditions in vivo, but rather a thermodynamically open environment that
involves the dynamic flow of body fluid [34]. Therefore, it is more rep-
resentative to subject 3DP scaffolds to in vitro resorption under dynamic
flow conditions.
In this study, HA-CaSO⁠4 scaffolds were too fragile to handle fol-
lowing 7days immersion in the buffer solution. The HA-CaSO⁠4 scaffold
type demonstrated a high specific surface area due to high inter-par-
ticle spaces. When subjected to an abrasive attack from the dynamic
flow, this resulted in a rapid deterioration of structural properties. In
contrast, the PCL-HA-CaSO⁠4 scaffold type maintained increased struc-
tural integrity following 56days of immersion in the buffer solution.
Therefore, it was pertinent for the remainder of the study to focus on
the behaviour of the PCL-HA-CaSO⁠4 3DP scaffold type as oppose to its
PCL-CaSO⁠4 counterpart.
PCL-HA-CaSO⁠4 demonstrated a relatively fast mass loss from Day
0–28 (−48.65±0.80%) (Fig. 5). Following Day 28, further mass loss
continued at a slower rate (−54.48±0.54%) towards Day 56.
PCL-HA-CaSO⁠4 exhibited significantly lower mass loss than PCL-CaSO⁠4
between Day 28 and Day 56 (p<0.05). The use of continuous dy-
namic flow removed ceramic dissolution by-products from the 3DP scaf-
fold and reduced the potential for local ion oversaturation. Oversat-
uration of ions has the potential to confound the resorption process.
During the first 28days of in vitro resorption, a strong linear corre-
lation (R⁠2 =0.996) was observed between mass loss and resorption
time, suggesting a constant dissolution rate. The rapid resorption of
PCL-HA-CaSO⁠4 following 28days of immersion in buffer solution was re-
lated to the HA and CaSO⁠4. It was speculated that ceramics were readily
dissolved until a time when the remaining ceramic particles were encap-
sulated with PCL. Consequently, the rate of further resorption receded.
Water absorption of PCL-HA-CaSO⁠4 also increased rapidly from Day
0–28 (146.36±4.93%) (Fig. 6). Following Day 28, a gradual reduc-
tion in water absorption was observed. After 56days of immersion
in buffer solution, the PCL-HA-CaSO⁠4 scaffold exhibited water absorp-
tion of 106.11±1.92%. It was significantly lower (p<0.05) than the
PCL-CaSO⁠4 3DP scaffold throughout the testing period. Water absorp-
tion was a balance between removal of hydrophilic resorbing material
and the water uptake of surface flaws, which were created due to ma-
terial removal. The local regions where ceramic particles were exposed
to buffer solution became vulnerable due to dissolution. The dynamic
flow demonstrated sufficient shear forces to dislodge ceramic particles
from weakened regions, which created cavities on the surface of the 3DP
scaffold. These cavities are likely to have trapped buffer solution and in-
creased water absorption between Day 0 and Day 28, which represented
the period when the fastest mass loss was evident. Consequently, the
proportion of PCL increased (Fig. 7). It is a more hydrophobic material
when compared to HA or CaSO⁠4, and therefore the rate of water absorp-
tion of PCL-HA-CaSO⁠4 slowed after Day 28.
The compressive strength of PCL-HA-CaSO⁠4 decreased by 73.48%
from between Day 0 (2.64±0.18MPa) and Day 28 (0.70±0.10MPa)
(Fig. 8). Thereafter, there was no significant change in the compres-
sive strength until Day 56 (0.50±0.16MPa). After 7days of immersion
in buffer solution, the compressive modulus rapidly reduced to 37%
of the original compressive modulus. However, there was no signifi-
cant change (p>0.05) in the compressive modulus following Day 14.
On average, the 3DP scaffold retained 15% of its original compressive
modulus after 56days of immersion in the buffer solution. The com
pressive properties for PCL-CaSO⁠4 subjected to resorption followed a
similar trend. However, the reduction in both compressive strength
and compressive modulus for PCL-CaSO⁠4 was greater than those for
PCL-HA-CaSO⁠4 after Day 21. The compressive properties were affected
by the material removal from the 3DP scaffold structure. The greater re-
sorption between Day 0 and Day 28 resulted in a significant reduction
in compressive properties (p<0.05).
PCL was selected as the infiltration material because it can provide
long-term mechanical stability to withstand the forces exhibited during
the early stages of wound contraction and bone healing owing to its
relatively slow resorption profile in contrast to other biopolymers, e.g.
poly(lactic‑co‑glycolic acid) (PLGA) [35]. Additionally, PCL offers bet-
ter ductile characteristics when compared to poly‑l‑lactic acid (PLLA),
which can help augment the brittle nature of the HA-CaSO⁠4 and there-
fore improve its fracture resistance and structural retention during phys-
ical loading [26,36]. An important issue to consider when using a sol-
vent (e.g. chloroform) to dissolve the PCL is to ensure its complete re-
moval before clinical application as this will be critical to the cellu-
lar behaviour of the PCL coated 3DP scaffolds. Peroligo et al. (2007)
used differential scanning analysis to confirm that full evaporation of
the chloroform from a PCL coated bioceramic scaffold structure can be
achieved within 24–48h [37]. They concluded that full evaporation of
the chloroform was achieved within this time frame since a relatively
thin coating of PCL with a high surface area was used – which was also
the case in this investigation. Additionally, Tarafder and Bose (2014)
used a solvent to dissolve PCL prior to coating tricalcium phosphate 3DP
scaffolds and reported no adverse effect of PCL on the biocompatibility
of the scaffold or its in vivo bone forming capabilities after six weeks im-
plantation [38].
The diffraction peaks of the CaSO⁠4 from the XRD spectra for the
PCL-HA-CaSO⁠4 attenuated greatly during in vitro resorption (Fig. 7). The
CaSO⁠4 phase (1) was difficult to detect after Day 56 and HA (3) became
the dominant inorganic phase detected. The organic phase, PCL (2), also
remained within the 3DP scaffold structure, exhibiting diffraction peaks
at 2θ=21.3° and 23.7°. This result indicated that CaSO⁠4 experienced a
more intensive level of dissolution when compared to the HA phase. It is
well known that CaSO⁠4 dissolves more rapidly than β-TCP and HA [39].
The loss of scaffold mass was attributed to the steady dissolution of
CaSO⁠4, which was exposed directly to the buffered solution. The remain-
ing CaSO⁠4 was encapsulated by PCL and therefore, was unable to be de-
tected towards the end of resorption. The absence of CaSO⁠4 during the
latter stages of resorption could provide several benefits: firstly, its rapid
dissolution released a large amount of Ca⁠2+ ions, which would favour
cell proliferation in vivo [40–41]. Secondly, the removal of the CaSO⁠4
left behind empty spaces that could enhance new bone formation [42].
HA remained almost passive because the resorption of multiphase-ce-
ramic always begins with the dissolution of the most soluble phase [42].
The greater dissolution of CaSO⁠4 created an environment rich in Ca⁠2+
ions, which also inhibited HA dissolution. The SEM analysis showed that
a large number of ceramic particles remained within the 3DP scaffold
at Day 56, which were connected by PCL fibrils (Fig. 9). Additionally,
the scaffold surface was still well covered with the PCL coating layer.
Therefore, a high level of structural integrity was still available after the
3DP scaffold was subjected to dynamic in vitro resorption for 56days.
This signifies the potential for the 3DP scaffold to offer structural and
mechanical support to the newly formed tissues.
During the 3D printing process, a solid structure was formed due to
the precipitation of ceramic aggregates when the setting reaction be-
tween the CaSO⁠4 powder and water-based binder occurred (Fig. 10).
The aggregated rod-like crystals eroded when the structure was sub-
jected to resorption in the buffer solution. The surface erosion resulted
in a smoother topography, which was observed for the PCL-HA-CaSO⁠4
morphology after 28days immersion in buffer solution. More signifi
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cant erosion was demonstrated when the resorption proceeded to Day
56. These results demonstrated that the mechanism of surface erosion
was dominant, whereby the material located within the internal struc-
ture only resorbed following complete resorption of the external sur-
faces.
One of the challenges of analysing resorption using μ-CT is the con-
tinuous shift of the X-ray absorption peaks on the grayscale histogram,
which was proportional to the material density [29]. A decrease in ma-
terial density related to the microporosity created as a consequence of
the resorption process. A voxel containing an element of microporos-
ity exhibited a relatively low grayscale value. A more dramatic shift
of the X-ray absorption peaks towards lower values was observed on
the grayscale histogram of PCL-CaSO⁠4 3DP scaffolds compared to their
PCL-HA-CaSO⁠4 counterparts (Fig. 11). There was no distinct peak ob-
served on the histogram for PCL-CaSO⁠4 3DP scaffolds between Day 42
and Day 56. To demonstrate material distribution at different stages of
the resorption period, binary images of cross-sections of 3DP scaffolds
were generated via thresholding the reconstruction images at different
grayscale levels based on the histograms: (1) 24–255 for PCL-HA-CaSO⁠4
and (2) 5–37 and 37–255 for PCL-CaSO⁠4 (Fig. 12). The cross-sectional
images of PCL-HA-CaSO⁠4 after 56days of resorption did not exhibit a
significant change and a high level of structural integrity was main-
tained. Smaller pores (approx. 100μm) were created within the struc-
ture after 56days of resorption. However, PCL-CaSO⁠4 scaffolds experi-
enced a rapid loss of material (Fig. 13), which correlated to a lower
grayscale range at Day 28 as a consequence of the reduction in den-
sity throughout the 3DP scaffold. This transformation continued to be
more significant as only a few materials were observed on the binary
images at Day 56. The dip-coating technique enabled deep infiltration of
PCL within the scaffold structure, which efficiently filled the inter-par-
ticle spacing. The entire 3DP scaffold structure was maintained due to
the PCL demonstrating a low level of resorption by Day 56. Due to this
infiltration of PCL within the 3DP scaffold it was highly unlikely that
large spaces were created unless the in vitro resorption reached a rela-
tively high level, which was the case for the PCL-CaSO⁠4 3DP scaffold
type. However, for the PCL-HA-CaSO⁠4 based 3DP scaffold, both PCL in-
filtration and faster dissolution of CaSO⁠4 reduced HA dissolution. Con-
sequently, a large amount of HA particles remained within the 3DP scaf-
fold structure.
This study has been focused on the printability of the polymer
coated composite materials and the corresponding in vitro data reported
over a 56-day period shows promise. Notwithstanding this fact, there
may be additional questions that are still unresolved and areas for fur-
ther development. Although, use of the PCL coating successfully in-
creased the compressive strength to match cancellous bone (2–12MPa)
[3], the compressive modulus was still lower than that of cancellous
bone (100–500MPa) due to the loose packing nature of ceramic par-
ticles. Further improvement in the compressive properties could be
achieved through: (1) optimisation of the particle characteristics to
achieve more dense powder packing, or (2) incorporation of ceramic
particles within the polymer infiltration solution for better structural re-
inforcement. Further investigation is necessary to understand how the
PCL-HA-CaSO4 based 3DP scaffolds perform under cyclic loading within
a pseudo-physiological environment as this is an essential next step be-
fore in vivo testing using an appropriate animal model. Studies regard-
ing the cytotoxic response of both HA and CaSO⁠4 based biomaterials
have documented favourable findings corroborating their potential in
orthopaedic applications [14,25,38,44-46]. However, there may be tox-
icity issues associated with our composite scaffold since the materials
were processed via a novel technology. It is important that compres-
sive and tuneable resorption properties of the 3DP scaffolds are ap-
propriately balanced to the sequence of events exhibited during new
bone formation in vivo, i.e. encouraging new tissue growth during the
initial stages of implantation, offering sufficient structural and mechan-
ical support, and following an appropriate resorption profile during
the bone healing phase. This balance can be achieved by varying the
CaSO⁠4:CaP:PCL of the final material formulation to mimic the mechan-
ical properties and resorption requirements for a specific clinical appli-
cation, which will vary considerably depending on a number of factors,
e.g. the age of patient, bone quality, size, and anatomical site of the de-
fect. Further work is currently ongoing to (1) augment the mechanical
properties of the existing 3DP scaffolds and understand how they per-
form under cyclic loading within a pseudo-physiological environment,
(2) determine the extent of biocompatibility and osteogenic properties
of these 3DP manufactured scaffolds using an appropriate in vivo ani-
mal model, and (3) understand if the 3DP scaffolds offer the necessary
mechanical and structural support and resorption rate required for com-
plete repair of a critical sized bone defect and coincide with the se-
quence of events involved in natural bone healing.
4. Conclusion
This study demonstrated that a blend of HA and CaSO⁠4 was a reli-
able formulation for powder-based 3DP technology. The combination of
using a fast resorbing CaSO⁠4 powder and the relatively slower HA pow-
der represents a promising prospect for tuning the bioresorption of 3DP
scaffolds. The HA-CaSO⁠4could be tailored to coincide with tissue growth
rate for different surgical procedures. Following manufacture of the 3DP
scaffold, PCL infiltration was used to successfully fill the inter-particle
spacing within the scaffold and as a result, the compressive properties
increased significantly. The in vitro resorption properties under a dy-
namic flow conditions demonstrated PCL inhibited HA dissolution and
maintained the overall structural integrity after 56days of resorption.
The remaining scaffold structure accounted for 45.52±0.54% of the
original mass. Rapid reduction in the compressive properties during the
first 28days were mainly attributed to CaSO⁠4 dissolution. The majority
of the CaSO⁠4 powder resorbed within 56days, while HA remained al-
most passive. The resorption of the CaSO⁠4 particles allowed for spaces
to become available, which could act as niches, encouraging new tissue
growth in the vicinity of the slow resorbing HA. The prepared HA-CaSO⁠4
scaffold with enhanced mechanical properties and tuneable bioresorp-
tion has potential as a good candidate for bone tissue engineering appli-
cations.
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